© Copyright, Research Institute of Dallas, 2006. All rights reserved.Site creation Levity Design and Advanced Tech Enterprises

Member of the Endocrine Associates of Dallas, PA
Research Institute of Dallas is currently enrolling participants in studies who meet the following criteria:

DIABETES STUDIES
Diabetics on insulin, with asthma, no smokers
Diabetics on insulin, with COPD, no smokers
Type II diabetics on insulin
Type II diabetics currently on 2 oral medications
Type II diabetics currently on 3 oral medications

NEUROPATHY STUDIES
Diabetics currently on Elavil
Diabetics currently on Neurontin

NEPHROPATHY STUDIES
Type II diabetics with protein in your urine and high blood pressure
Type II diabetics with protein in your urine

HYPERLIPIDEMIA STUDIES
Males, age 55 or older; females, age 65 or older with elevated cholesterol

HYPERTENSION STUDIES
Diabetics currently on high blood pressure medication

OSTEOPOROSIS STUDIES
Subjects diagnosed with osteoporosis

CARDIOVASCULAR STUDIES
Heart attack, angina or stroke within the last 6 months

If you are interested in participating in any of the above studies, please contact us for further information.
 
TEL 214.265.2137     FAX 214.265.2164
Director
Stephen Aronoff, M.D., F.A.C.P., F.A.C.E.

Medical Board
Richard Sachson, M.D., F.A.C.P., F.A.C.E.
Steven Dorfman, M.D. F.A.C.P., F.A.C.E.
Mitchell Sorsby, M.D. F.A.C.E.
Audrey Miklius, M.D., F.A.C.E.
S.K. Lakhian, M.D., F.R.C.P. (C)
Heidi Chamberlain Shea, M.D., F.A.A.P.
The mission of Research Institute of Dallas, P.A. is to provide the clinical research industry with a facility that continuously strives to conduct cost efficient Phase II - IV clinical trials while demonstrating integrity and compassion for our patients.